Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid
Condition(s):Gout Chronic; HyperuricemiaLast Updated:February 14, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Gout Chronic; HyperuricemiaLast Updated:February 14, 2022Completed
Condition(s):HypercholesterolemiaLast Updated:May 7, 2021Completed
Condition(s):Primary Biliary CirrhosisLast Updated:July 14, 2022Completed
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:November 4, 2022Completed
Condition(s):Short Bowel SyndromeLast Updated:October 13, 2021Completed
Condition(s):Lupus Erythematosus, SystemicLast Updated:August 20, 2020Completed
Condition(s):Non Hodgkin LymphomaLast Updated:December 19, 2023Active, not recruiting
Condition(s):Cystic FibrosisLast Updated:March 4, 2020Completed
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:June 9, 2023Completed
Condition(s):Uveitis; Uveitis, Posterior; Uveitis, Anterior; Uveitis, Intermediate; PanuveitisLast Updated:June 2, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.